Body mass index does not impact hematopoietic progenitor cell mobilization for autologous hematopoietic cell transplantation.
CONCLUSION: Obese AHCT recipients had similar rates of HPC mobilization, neutrophil and platelet engraftment and length of transplant hospitalization, and experienced better survival compared with recipients with lower BMI. High BMI by itself should not be considered as a contraindication to AHCT.
PMID: 31381194 [PubMed - as supplied by publisher]
Source: Clinical Lymphoma and Myeloma - Category: Cancer & Oncology Authors: Khouri J, Rybicki L, Majhail NS, Kalaycio M, Pohlman B, Hill B, Jagadeesh D, Dean R, Hamilton B, Sobecks R, Koo A, Liu H Tags: J Clin Apher Source Type: research
More News: Cancer & Oncology | Chemotherapy | Eating Disorders & Weight Management | Hodgkin's Disease | Lymphoma | Myeloma | Non-Hodgkin's Lymphoma | Obesity | Radiation Therapy | Study | Transplants